Annual Report and Financial Statements 2020 Crohn's and Colitis UK CROHN"S& COLITISUK Annual Report and Financial Statements for the year ended 31 December 2020 Crohn's and Colitis UK- trading as Crohn's & Colitis UK Registered Charity No. 1117148 (England ond Wales) SC038632 (Scotland) A Company limited by guarantee in England and Wales No. 05973370 Annual Report and Financial Statements 2020 Crohn's and Colitis UK CONTENTS Strategic Report...-...............................-..........-.........-..........-...............................-...............................-..........-...................... Our Goal- We wont everyone to understand Crohn's ond Colitis................................................................... Our Gool- We wont to drive world closs research into the disease...-....................-..........-............................ Our Goal- We want to support people ond empower them.............................................................................. to be active participunts in managing their life with Crohn s and Colitis...-.......-..........................-..........-..... Our Gool- We wont high quolity, sustoinoble. clinical core across the UK.......................-..........-.......-....... Our Goal- We wont early ond occurate diagnosis for all.................................................................................... Enobling the charity to achieve our gools..-..........-.........-..........-...............................-............................................. Plans for the future.......................................................................................................................................................... Funding our work..............................................-.........-..........-...............................-...............................-.......-..........-....... Governonce, structure and manugement...-...............................-...............................-...............................-..-......-..-...11 Legol status ond objects................................................................................................................................................11 Public benefit...-...............................-..........-....................-...............................-...............................-..........-......................11 Members............................................-.................................................................................................................................11 Trustees ond organisotionol structure...................................-...............................-...............................-..................11 Subsidiary undertoking.................................................................................................................................................12 Employees...-...............................-...............................-..........-....................-...............................-.....................................12 Volunteers...................................-...............................-...............................-...............................-...............................-......12 Risk review.........................................................................................................................................................................13 Financial review...-...............................-..........-....................-.......-.......................-...............................-..........-.....................14 Cornpliance........................................................................................................................................................................14 2020 results..............-....................-...............................-...............................-..........-.........-..........-..................................14 Reserves Policy...-..........-.........-..........-...............................-...............................-...............................-............................14 Cash and investments...................................................................................................................................................15 Pension costs...................................-....................-..........-...............................-...............................-.........-..........-...........15 Staff remuneration.........................................................................................................................................................15 Gront moking policies...-...............................-...............................-...............................-..........................................-......16 Research grants...-..........-....................-...............................-...............................-..........-.....................-....................16 Locol grants....-.............................................................................................................................................................16 Statement of responsibilities of trustees........................-..........-...............................-...............................-..................17 Independent auditor s report............................................................................................................................................18 Finoncial stotements...................................................................-...............................-................................-....................22 Consolidoted Stotement of Financial Activities...............................................................................................22 Bolonce sheets ut 31 December 2020...................................-....................-..........-..............................-...-.-...23 Consolidated Stotement of Cash Flows...-...............................-...............................-..................................-......24 Notes to the Accounts..............................................................................................................................................25 Adrninistrotive detoils........................-..........-...............................................................-....................-..........-.......-.......-... 38 Board of Trustees, officers and senior monagement teom............................................................................ 38 Boord Committees...-.......-.......................-...............................-...............................-...............................-.................... 38 Professionol services...-...............................-...............................-...............................-............................................-...39 Thank you so much............................................................................................................................................................40 **Crohn’s and Colitis UK** **Annual Report and Financial Statements 2020** Sue Cherrie (May 14, 2021, 9:43am) Sarah Sleet Sarah Sleet (May 11, 2021, 5:12pm) Annual Report and Financial Statements 2020 Crohn's and Colitis UK Who we ore We are the UK s leading chority for Crohn s and Colitis. Right now. over 500.000 people are living with these lifelong conditions that too mony people have never heard of. We ore working to improve diognosis and treotrnent, und to fund reseorch into o cure, to raise owareness and to give people hope, comfort ond confidence to live freer, fuller lives. OUR VISION: lrnproved lives todou A world free frorn Crohn s and Colitis tomorrow OUR MISSION: We break taboos We drive pioneering research We support and bring people together We cornpaign to improve lives We are leading the fight against Crohn s and Colitis OUR VALUES: We are ornbitious We are cornpassionate We ore stronger together How are we working towards this vision? We provide high quality information, practical help and support thot enables people to manage their conditions. We believe people living with Crohn's and Colitis should be able to live their lives to the fullest. We work with the UK heolth sector to improve diagnosis, treatment and monogement of IBD1 We want everyone with the conditions to have access to the best specialist services. We support liftrchanging research to increase knowledge of the causes, ond the best treatrnents for Crohn s and Colitis. We want to improve lives now and lead the mission to find a cure. We campaign vigorously - for more knowledge. better services and more support for our ongoing fight against IBD. And we're doing it in line with our values of boing compassionate, arnbitious, and stronger together. IBD- Inflammatory Bowel Oi5ease Annual Report and Financial Statements 2020 Crohn's and Colitis UK Strategic Report We are working towards five strategic gools. set out in 2018. which will make a positive impact on the lives of people with Crohn's and Colitis. In 2020. of course. we had to face the exceptional challenges of a global pandemic. We rapidly adjLASted our plans for 2020 to focus on supporting our community through the crisis. ensuring they were not forgotten in society s response to the pandemic. And despite the challenges. we continued to make progress against all five aims. Our Goal - We want everyone to understand Crohn's and Colitis Amid o worldwide pandemic, 2020 was the year we needed to stand up for people with Crohn's and Colitis more than ever. At the start of 2020 our NotEvery tjsability is Visible compaign was making progress with mony restaurants and pubs changing their toilet signage ond training stuff to recognise and support people with Crohn s ond Colitis. The impact of COVID-19 meant o rapid switch to campaigning to keep public toilets open ond keeping our community s needs in the public spotlight. When shops and facilities reopened in summer 2020, public toilets remoined closed and with compuigners support we achieved notionol coverage in broadcost and print media of Dur cumpaign to reopen toilets. Our safety guidance was distributed by the Locol Government Association to all local authorities in England & Wales, with mony committing to reopen accessible toilets during the notional lockdown and continuing to engage with us to implement Not Every Disability is Visible signage across public facilities. Many in the Crohn s ond Colitis community are particularly vulneroble ond we needed to make sure their voices were heard. 8,000 people took part in wr Life in Lockdown survey thot highlighted where rnore needed to be done to support our community in their workploce, in occessing healthcare ond shielding support. It provided the evidence we needed for many of the octivities we report on below. We worked with other charities to ensure our concerns were heard in government and the health service. Our Goal - We want to drive world class research into the disease 2020 hos been o year of finding alternative ways to support research. Our role in putting the patient ot the centre of research is flourishing. We promote recruitrnent to research studies ond in 2020 our efforts contributed 67% of the researchers recruitTnent targets. We livestreamed through Zoom, for the first time, our patient research participation day. It uttrocted 299 attendees- our biggest audience yet. The event wos viewed over1,000 times on YouTube and the online feedback will go on to shupe the research presented We continue to invest in existing research projects but the impact of the pandemic on our incorne meant we were unable to fund new projects in 2020. Nevertheless, aght of the chority's projects were ableto complete in 2020 with our funding: A new strotegy to limit fibrosis in Crohn s disease Being Me with IBD= Growing up and getting on with rnu life Comparison of cornbination antibiotic and hydroxychloroquine therapy in active Crohn s From genetic varionts to o better understanding of IBD susceptibility MicroRNA profiling in Inflammatory Bowel Diseases Regulatory T cells in IBD- optimising their therapeutic potentiol Annual Report and Financial Statements 2020 Crohn's and Colitis UK Self-munagement intervention for poin in IBD The lived experience of family planning with IBD We continued to support our Pain Collaborative Network working on applications for further funding and owarded two grants of our owntackling the issue of poin: Feosibility testing of an occeptonce ond commitment group theropy intervention Identifying risk factors for the development of chronic abdominal poin in patients with IBD We continued to lead the potient input and comrnunicotions work of Gut Reoction - the Health Datu Research Hub for Inflammatory Bowel Disease. This unique collaboration is building the largest IBD datoset in the world. Potient input to the progromme hos led to a redesign of the approach to data access requests for the Hub and the NIHR BioResource. a critical part of the UK s research infrastructure. Our Goal- We want to support people and empower them to be active participants in managing their life with Crohn's and Colitis 2020 highlighted the chority's pivotal position as a trusted source of accurate and expert inforrnotion in the frightening and rapidlu evolving environment of the pandemic for thousands of people with Crohn's and Colitis. We were there for more people than ever before, onswering16,000 queries vio phone calls, emails and Livechat providing informotion and support. In March we hod o 644% increase in emails ond 0121% increose in phone calls to our Helpline becouse of the pandemic (cornpored with March 2019). There were1.8 million page views of our COVID-19 poges which included critical information on ossessing COVID-19 risk levels to inform sociol distancing and shielding decisions. Over 95% found our informotion helpful and our Life in Lockdown survey suggested the charity wos the top source of information for COVID-19 for people living with the conditions. We gave our comrnunity fast access to expert advicethrough new Facebook Live events covering subjects such as voccinotions and well-being. Theu attrocted 279.000 attendees. More people turned to our digitol channels such as Instagrarry Facebook, Companion website and Facebook Forum for support. Our Facebook poge grew by over 3% to 202,500 likes while our Forum membership was up by 20% (to 48,700). Our Instagram followers grew by 26% (55,300) and our Twitter followers rose by 31% (48,200). We successfully piloted virtuol social events to reploce the face to face meetings held by our volunteer networks- a new approach which reoched out to those previously unoble to ottend fuce to face meeting& This innovation will become a permanent offering. Our Goal- We want high quality. sustainable. clinical care across the UK The pandernic threw up more chollenges thon ever in access to diagnosis and high qualitu core. We worked hard with clinical leaders to ensure patients with Crohn s and Colitis were not forgotterL Throughout the pandernic we worked with heolthcore professionals and their orgonisations to ensure easy occess to criticol information for patients. With the pressures on hospitol staff dealing with COVID-19, many patients were not able to ask direct questions of their IBD teams as they normally would. The charity was able to step into the information vacuum reassuring potients and rernoving some of the pressures on NHS staff. Annual Report and Financial Statements 2020 Crohn's and Colitis UK We worked with key professionol bodies to help develop u potient friendly COVID-19 risk ossessment opprooch which proved vital for putients- our research highlighted that1 in 5 were assigned the wrong risk level by the NHS in the earlu days of the pundemic which led to some patients unnecessarily shielding while others were not toking the right sociol distancing measures. Accurate risk assessrnent would ulso prove criticul to prioritisation for vocoinatiorL We also pressed the case for appropriate prioritisotion of patients with Crohn s and Colitis in hospital services which were highly restricted due to the impoct of COVID-19, particularly advocating for better occess to endoscopy and surgery. As o result, surgery guidelines ore clear that patients in need of treatment should get the access they need. Our work to improve the standards of Crohn s und Colitis core overoll continued throughout 2020. As chair of IBD UK. on alliance of17 potient charities and healthcare professional organisations. we released reports on local Inflammotory Bowel Diseose (IBD) services performance against the new IBD Standurds. Further work on o national report was prepared for launch early in 2021 and is expected to make a mojor contribution to IBD service improvement, raising standards of care through quality improvement. Through our ongoing collaboration with the Scottish Government and three Health Boards, we won "Self-manogernent Resource of the Year in the Self-management Awards, run by the He0￿h and Social Core Alliance Scotland for the development of o flore card. co-designed by patients with Crohn s and Colitis. In Wales, we were delightedthot IBD was recognised us on NHS priority through the establishment of the role of IBD Clinical Leod for Wales. This follows years of focused chority activity to raise the profile of IBD, including through the estoblishTnent of the IBD Woles group and political events in the Senedd. Services fully centred oround the needs and wishes of potients remains elusive. In October we won o Heolth Foundotion grant worth £475k over 3 years to support potientsto drive changes in services. We will be working in partnership on AWARE IBD with three Sheffield based orgunisotions on the project.. Sheffield Teaching Hospitols NHS Foundation Trust University of Sheffield VoiceAbilitu Our Goal - We want early and accurate diagnosis for all 2020 sow the successful cornpletion of our focus on supporting general proctitioners in the care of patients with Crohn s and Colitis Our successful three year Spotlight Project in partnership with The Royal College of General Practitioners (RCGP) finished in March 2020. Since the development of the IBD Toolkit for GPS, it has been viewed over16,000 times across the UK. It has also been viewed by users as far away os Moloysia, Saudi Arobia. Colornbio, the Faroe Islonds ond Brunei. Now the project hos finished, the IBD Toolkit will continue to be hosted by RCGP ond discussions are ongoing to ensure it remains up- to-date and widely promoted. The RCGP IBD Clinical Chumpions programme ended in March 2020, but we continue to work closely with GPS and ullied heolth professionols across the UK. Annual Report and Financial Statements 2020 Crohn's and Colitis UK Enabling the charity to achieve our goals 2020 triggered the rapid reorgonising of our services and resources to provide the critical support needed by our community in challenging times. The pandernic radically impucted on the environment the charity was working in and its income. We hod to take swift action to ensure the sustainotmlity of the charity for the future. As a result, we redirected our work to criticol octivities supporting peoTJe with Crohn s and Colitis through the pandemic ond shifted delivery online. We needed to reduce our cost base by o quarter in recognition of the reduction in income, including using the furlough scheme where the pandemic had led to reduced activity and usking our working staff to reduce their hours ond pay to 80% of their usuol leve￿ for seven months. To create longer term stability, we also looked hard at creating on agenda thot was more tightly focused and we consolidated activities wherever we could. Subsequently, we completed o restructure of the charity by October 2020 which sudly led to o loss of12 roles. We are groteful to all staff throughout this difficult time ond continuing to put the needs of our community first. We ore ulso groteful to ull our supporters in 2020, without whom we would not be here to deliver for our community. Despite the challenges of the year, we embedded our new Microsoft Dynarnics Customer Relotionship Manogement (CRM) database os planned increasing productivity along with better insight ond onulysis of the effectiveness of our work and improved stakeholder relationships. This large investment of the chority will be fundamentol to its ability to deliver going forword. Plans for the future As we enter 2021, we ore working in very chonged circurnstonces. OUT current strategy was due to complete in 2022 but we decided to bring forward the strategy review to the first six months of 2021 to adopt to the new world. We are conducting the review with external input where needed to ensure that we ore clear about new opportunities and challenges for the charity. We leornt in 2020 how fast the charity con adapt and innovate, ond we want to rnake the most of these positive qualities going forward. During the uear we will olso deliver: The national report on how UK gastroenterology services are performing against the IBD Standards. This will be the launchpod for engoging with government, the NHS and clinicions on the improvements needed for better care. We will deliver a new Not Every Disability is Visible compaign focused on the workplace ond develop and launch u new compoign to increose symptom owareness in the public ond omongst key community clinicians We will build rnore information resources for our community and muke them more accessible. We will do Tnore to understand the diverse comrnunities we work for ond how they can be better served. We will redevelop our digitol platforms to better serve oll our oudiences. Annual Report and Financial Statements 2020 Crohn's and Colitis UK Funding our work We greatly vulue and rely upon the trust of our supporters. Our fundraising is conducted in compliance with the law. We support the Fundroising Regulator s Promise ond we are o member of the Fundruising Regulutor s scheme, which hold Members to set standords for charitable fundraising. Crohn s & Colitis UK odheres fully to oll guidelines ond standards produced by The Fundraising Regulator and we proudly disploy its logo on all our public fundroising rnoteriols. To maintain our supporters trust we ore open. honest, fair, ond legul in our fundraising practice. There were no compliance issues with the Fundruising Standards we have adopted. In 2020 we received six complaints (six in 2019) obout our fundroising representing atiny proportion of our interactions. How we hove roised the money 2020 was uniquely challenging for all charities roising funds and we ore no exception. The irnpact of lockdown on our supporter events was significant ond overall fundraising income fell by 29% compored with 2019. However, our Community of supporters wos very generous. ond kindly helped us throughout the ueor in various woys. In 2020 donations from individuals sow a slight increase despite it being o difficult year for many people. We ure very grateful for their continued support. We sent an emergency appeal mailing to15.000 of our supporters and received donations totolling over £58,000. As a result of this oppeul, we saw o significant increase in the number of Regular Gifts. In on overage year we recruit 180 new Regular Givers but in 2020 we sow this nurnber increase by 522. Our corporate supporters were invaluable. with income growing to over £695,000 in 2020 (£622.696 in 2019), the highest total in the charity s history. New funding wus secured to support our Specialist Nurse Programme in 2021 and we are groteful to our pharmaceutical partners who responded to our emergency appeal. As our corporate portners closed offices ond staff worked from home. employee fundraising octivities were severely impocted. However, our purtners generously supported in new ways where they could, toking part in our virtuol World IBD Dau coffee morning, RunThe Night ond more. Partners such os Insight Direct, kindly offered to postpone their fundraising for us or extendthe partnership instead, and others offered generous ontroff pundemic related funding, following staff nominotions. In partnership with TruckAdz we ulso launched our first Crohn s & Colitis UK branded lorry 'It Takes Trucks'l The response from Trusts and Foundotions to our emergency funding applications sow us receive new grants including an award from the Coronavirus Community Support Fund. distributed by The Notional Lottery, towards our Helpline Services. This generous response to the Helpline wos echoed by mony trusts and foundotions, several of which were new to the charity. We also secured o three-year portnership oword frorn The Heolth Foundation, in support of our work with local portners in Sheffield to re-design Inflammatory Bowel Disease services, shaped by the patients who use them. We developed innovotive fundroising activities in response to the pandernic, introducing virtual events such os our online World IBD Doy coffee moming and a quiz night with TV presenter Chris Tarront. We also received income from new plotforrns including Tiltify, where funds were generated by live vid8) gameplay on Twitch.1.825 of our Facebook followers fundraised for us, raising olmost £226,000. Events income was heovily irnpacted but still ruised £700,000 despite the postponernent of events such as London Marathon and Great North Run. Our own flagship events WALK IT and Run The Night were sodly concelled, but we created virtual versions which generated over £136,000. Actor, Sacha Dhawan, who hos Crohn s diseose. ran with his partner Anjli. covering the10 kilometres neartheir home and ruising more than £3,000. We connected with our supporters in new woys including video messages which proved hugely successful. We will continue to introduce new ways to cornmunicote ond thank our supporters in 2021. Annual Report and Financial Statements 2020 Crohn's and Colitis UK We secured ond retoined partnerships, or received donations from the following componies to whom we extend our sincere thanks for their support.. Abbvie (UK) Alco Arnozon Smile Amgen Arena Pharmoceuticols Aururn Bruckfern Lirnited Drug Stors Ergonomic Solutions Ferring Phormoceuticals Golapagos UK Gilead Hovas Foze Herb Kingdom Innovative Trials Invesco Cores Insight Direct Jonssen Kensington Mortgoges Lendinvest Lloyd's of London London North West University Heolthcore NHS Trust Merck. Sharp & Dohme Lirnited MNB Properties Ltd Norgine Parkmon George Pennies from Heaven Pfizer Roche Products Limited Sondoz Smith & Nephew Tokeda UK Ltd Taulor Wimpey West London Trusts and Foundations We would like to express our sincere and heartfelt gratitude to all our Trust and Foundation funders, including- Alexander Moncur Trust Crispo Charituble Trust Eveson Charitable Trust Fairfield Choritoble Trust Februory Foundation Garfield Weston Foundotion Hugh Froser Foundation John James Bristol Foundotion Medicosh Foundation Notional Lottery Community Fund (Englond ond Scotland) Notionol Lottery Community Fund (Coronavirus Cornmunitu Support Fund) Peter Sowerby Foundotion Price Purry Charitable Trust Roger und Douglas Turner Charitoble Trust Souter Charitable Trust The Childwick Trust The D'oyly Corte Foundotion The John Cootes Choritoble Trust The Lowson Trust The Moondonce Foundotion The Waterloo Foundation W O Street Charituble Foundotion Wixamtree Trust There were no complionce issues with the Fundroising Standards we have adopted. We do not employ professional fundraisers but do partner with third porty plotforrns to enoble online fundraising. Our lottery and raffles are licenced and reguloted by the Gambling Commission, ond we ensure that oppropriate informotion and support is in place to tackle problem garnbling. Fundraising activities which include children ond/or vulnerable adults must comply with our Safeguarding Policy, ond staff are trained in safeguording principles. Crohn s & Colitis UK stoff are guided by our Fundraising Policy ond have o responsibility to thoroughly understund and comply with the policy, within which we provide guidance on the legol ospects of fundraising and our ethical commitments 10 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Governonce, structure ond management Legal status and objects Crohn s and Colitis UK is a Cornpany Limited by Guarantee in England und Woles no. 05973370 and is a charity registered in England und Wales no.1117148 and in Scotlond no. SC038632. The charity is governed by its Articles of Associotion, lost amended in Septernber 2017. The charity s objects, os set out in its constitution, are.. the relief of those suffering from Ulcerative Colitis, Crohn s Diseose or related inflammatory bowel diseases (together. generally referred to os IBD) including the support of those who core for them. the promotion of the welfare of those suffering from Ulcerotive Colitis, Crohn's Disease or reloted inflamrnotory bowel diseases. the odvoncement of education and research into the causes, prevention, treotment ond cure of Ulcerative Colitis, Crohn s Disease or related inflammatory bowel diseases, improvements in the munogement of the conditions, and the publication of the results of such research. Public benefit In accordance with the Charities Act 2011, Crohn s and Colitis UK is required to confirm that the activities it undertakes to achieve its objectives are all corried out for public benefit os described by the Churity Commission. It should be noted that oll the chority s information und support services ure open to non-members to use as well as members. We hove demonstrated in this report how we have met the objects above. Members In 2020 due to the impact of the pondemic we ended the year with slightly fewer members at 44,000 (a drop of 2.2% from 2019.) We are very grateful to our members for their ongoing comrnitment ond support. Due to the pandemic the intended 2020 AGM was postponed untd Autumn 20ZI. We look forward to welcoTning our members then. Trustees and organisational structure The constitution provides for a Bourd of Trustees comprising four honorary officers plus no fewer thon three and not more than eight ordinary Trustees, elected ot the onnual general meetings of mernbers. New Trustees are appointed through o trunsparent recruitment and selection process and ore elected for an initial period of three years following which they are eligible for re-election for two further terms of three yeors. Once elected, they receive inductions that include spending time at the chority s offices, meeting with the Senior Leadership team, engoging with stuff, attending an external Trustee induction course ond being supplied with a Trustee Handbook. The Board of Trustees has responsibility for the governance and strategic direction of the charity, ensuring thot the charity upholds its ethos ond vulues and delivers its objectives. Authority for the operotion of the charity is delegated to the Senior Leadership Team (SLT), led by the Chief Executive, who reports to the Trustees to the levels described in a Scheme of Delegation last reviewed by the Boord in November 2020. 11 Annual Report and Financial Statements 2020 Crohn's and Colitis UK The Trustees have the power to co-opt advisers as non-voting members of the Boord and appoint committees. There were four committees of the Boord in 2020.. Finance ond Audit; Reseorch Strotegy and Funding- Govemance- and People and Orgonisotional Development. The Governance Cornrnittee wus stood down by the Board in November 2020. We olso had a Task and Finish Project Group chaired bu o Trustee to bring recommendations to the Board regurding IT/CRM sustems. Its work completed in 2020. The Trustees regulorly review progress ogoinst its aims und objectives at every Board meeting ond receive interim updates on irnportont matters through Board Comrnittees and electronic communication. A recruitment process for new Trustees was undertoken in the latter half of 2(J8 ond completed in 2020 following an audit to identify gaps in the Boord's skillset. The recruitTnent process used was refined to ernphasise the Board s desire to irnprove diversity ot the charity. At the end of the process four new Trustees were identified with a wide ronge of skills closing the skills gup and increosing our diversity. The Trustee Board met nine times during 2020 (five in 2019). The Honorary Officers, Trustees, Senior Leadership Team and committee members are as outlined on page 38 and 39. Subsidiary undertaking NACC Merchandise Ltd is a wholly owned subsidiory company of the charity. The principal activity of the company is the sale of Christmas cords and merchandise. Taxoble profits of £83.038 (2019= £11,208) weretransferred to the charity os Gift Aid under a deed of covenant orrongernent. More inforrnotion on the results of NACC Merchandise Ltd is given in note10 of the Financial Statement& Employees The charity storted the yeur with o complernent of74.7 fulltime equivalents Es) ond finished the year with 57.2 FtEs. The chonges were driven by our response to the pandemic. Crohn s & Colitis UK is committed to creating a great place to work. We recognise the direct link between employee sotisfoction and delivering our best for people with Crohn s and Colitis It is the charity s policy to provide equal opportunities to job applicants ond ernployees of any roce, nationolity, ethnic origin, marital status, religion or belief. gender. disobility, sexuol orientation, age or employment status. The charity does not condone or tclerate any form of discrimination in its recruitment or employment practices. Volunteers Volunteers continue to play a vital role in the work of the charity, and we value the tirne. dedication and support we receive from ull our volunteers and supporters. We are fortunate to have oround1,000 volunteers registered with the charity. Unfortunately. nearly oll our community-bosed volunteering activity hod to be paused during 2020. Nevertheless, some volunteers were able to continueto provide support remotely on our Volunteer helplines, readers ponel and supporting our databaseteam. We conducted our annual survey of volunteers to identifu how we can better support all our volunteers in future. 12 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Risk review The Trustees, with input from the Chief Executive and staff, have conducted a review of the risks to which the charity is exposed in its ongoing uctivitie& In particulor, the Trustees considered.. the tupe of risks the charity faces the level of risks they regord as occeptoble the likelihood of the risk concerned moteriolising the charity s obility to reduce the incidence and impact of risks that have been identified the costs of operating specific controls relative to the benefit obtained. The Trustees review risks in relation to ony new developments proposed ond the Finance ond Audit Committee reviews the full risk register (maintained by the SLT) at their quarterly meetings. The top line risks ure also discussed ot the full Trustees meeting on a quarterly bosis. The Trustees identified the following principal risks facing the charity.. The continuing impact of COVID-19 on income, plonning deliveru. staff morale and safety. Failure to consider equolity, inclusion ond diversity consistently throughout our activities. Sub-optimal management approach und comrnunication, staff development and inclusion leoding to poor stoff rnorole ond engagement Lack of diversity in financial income streoms ond over dependence on events. 13 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Financial review Complionce The financiol results for the y￿r are set out in the Consolidated Stotement of Financiol Activities (SOFA). This represents the total incoTne ond expenditure reloting to all octivities in the year. mode up of the work of the charity ut notional level, locol networks ond the octivities of the troding compony, NACC Merchandise Ltd. The figures in the following paragruphs ore taken from the SOFA and from the notes to the Financial Statements. 2020 results During 2020 the char￿Y hos mode on overall surplus of £618,293 (2019: £676,466 deficit) split between an unrestricted funds surplus of £237,067 (2019= £765,917 deficit) ond restricted funds surplus of £381,226 (2019: £89,451 surplus). Income has fallen significant￿ to £4,678,656 from £6247,473 in 2019 with COVID-19 leading to the canoellation of all our planned events due to government restrictions on muss gatherings and sociol distancing. In March 2020the cash flow was under pressure, and o big thank you to all of ournetworks who tronsferred excess funds to head office to help the irnprove the working capitol. In terms of expenditure, the charity's commitment to research grants was paused due to COVID-19 and only o single grunt for £145,700 (2019.. £1.131.133) was mode in the yeur, ulongside several writebacks in instonces where researchers reviewed their status os detailed in Note11 poge 29. Reserves Policy The Reserves Policy was revised by the Board on 5 February 2021 and outlines a frarnework to balance the need to maintain adequate funds to sustoin future activity with that of making best use of those funds raised and donated by supporters and partners. Total reserves increased to £2,688,578 (2019: £2,070,286) after the severe cutback in both income and expenditure in 2020. The chority holds restricted funds to the volue of £352,093 (2019= £135,042), which may only be used in accordonce with specific restrictions imposed by the donor. The charity also holds unrestricted funds to the value of £2,336,485 (2019: £1,935,244) of which £1,046,399 (2019: £938,698) were designated funds us follows.. Tongible Fixed Assets- A designated fund hos been created that represents the net book value of tongible fixed ossets insofar as these funds are not avuiloble for immediate use. Intangible Fixed Assets- A designated fund hos been created that represents the net book volue of intongible fixed ossets insofar us these funds ore not avuilable for irnmediute use. Local Networks retained funds- The Trustees olso agreed that any uccurnulated surpluses from the Volunteer Networks should be held for future use by Networks, and o designated fund has been established for this purpose. Networks are required to utilise these funds within two years of the end of the year in which they are reported. 14 Annual Report and Financial Statements 2020 Crohn's and Colitis UK The bolance of unrestricted funds not otherwise designoted represents the free reserves of the charity. In the light of COVID-19 and all the surrounding uncertointies, the Trustees have ogreed that in order to maintain adequate levels of working copital to fund day-to-day operations, and to protect the charity from income fluctuations and seasonal volatility, free reserves should be increosed to £1.2M (previously 8 weeks, equating to £0.6M). This is to represent a cornbinotion of on unexpected and immediate reduction in unrestricted income, alongside the need to meet core unrestricted expenditure ollowing the charity to continue to operate ond maintain its core services for six months. The current level is £1.3M This was considered a rnore realistic approach thun the previously held policy of 8 weeks when used alongside the lorge working capitol rnointained to fund long term research grants. Cash and investments The funds of the chority are largely represented by cash deposits including £98,922 (g296,904 in 2018) held by our Locol Networks, and investments held in a charity restricted ethical investrnent fund manoged by CCLA Investment Management. Pension costs The charity operotes a defined contribution pension scheme, established in 2015 through Legal & General. New employees are automaticollu enrolled in the scheme, ond staff that mau subsequently opt to leave the scheme will be re-enrolled after three years. Staff remunerotion Crohn s and Colitis UK is cornrnitted to ensuring a proper balance between (j) paying our staff fairly so that we attract and retain the very best people with the right experience and leodership quulities and (li) careful monugement of our charity funds. In so doing we ensure the greatest effectiveness in delivering our charitable objectives ond Meeting the needs of our beneficiaries. Stoff salories ore determined by reference to bonds that toke account of the levels of copobility ond experience required, uuthority and discretion levels. Our sularies need to be cornpetitive within the chority sector, but we do not uirn to compete on poy with the public or private sectors. Solories of the Senior Leadership Team, including the CEO, ore agreed by the Board of Trustees and will toke account of the past year s uchievements, environmental ond market conditions, and of sector comporison. Our work is dependent on voluntary donations and we oct in on open ond transparent way that respects the money, time and energy given by donors ond volunteers. In our commitment to openness, we disclose informotion about senior stoff solories within our onnuol report. This is in line with recommendations and guidelines from the Notional Council for Voluntary Organisations (NCVO). 15 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Grant tnaking policies Research grants Applications for grants for= MedicoL Living with IBD, and Heolth Service Development reseorch ore norrnolly invited on on annuol basis, but were deferred in 2020 due to the unexpected impact of COVID-19. Applicotions were previously considered by members of the Awards Panels, comprising ocadernic and rnedical speciolists as well as loy representatives. External specialist referees ure asked to comment confidentially on applications. Grants awarded in previous Years ore still progressing. Crohn s & Colitis UK has been oworded a Certificate of Good Practice for its peer review procedures by the Associution of Medical Reseorch Chorities. Gronts ore normally made for periods of up to three yeurs, with reports required ot onnuol intervols. Funds ore set aside for the totol cost of the project in the yeor of the award. The Research Strategy ond Funding Committee review and approve the recornmendutions of the panel by delegated authority from the Board of Trustees. Our website now has an area dedicated to reporting back, in'plain English,, on the findings from the research projects we fund. Local grants Locol Networks may make grants to locol hospitols to support or enhance aspects of the provision for IBD patients. Grants rnust be made according to the policy guidelines approved by the Trustees and generully cannot be made for items thut should otherwise be funded by the relevunt NHS TrusL In 2020 grants of £3,994 were mode (£27,916 in 2019). The reduction was due to Network funds being made available to the churity to mitigate cosh flow issues. 16 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Statement of responsibilities of trustees The Trustees (who ore also directors of Crohn s ond Colitis UK for the purposes of company law) ore responsible for preparing the Trustees report and the financial stotements in accordance with opplicoble low ond United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Cornpony low requires the directors to prepare financiol stotements for each financial year. Under that low the directors hove elected to prepare the finonciol statements in acoordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards ond applicoble law). Under company law the directors must not approve the finoncial statements unless they are satisfied that they give a true und fair view of the state of offoirs of the charitable company and of the incoming resources ond application of resources, including the incorne and expenditure, of the charitable company for that period. In preporing these financial statements, the directors ore required to.. select suitable occounting policies and then opply them consistently observe the methods and principles in the Charities SORP FRS102 (2019) moke judgements ond estirnotes that are reasonable and prudent state whether opplicoble UK Accounting Standurds have been followed, subject to any rnoterial departures disclosed ond explained in the Finoncial Statements prepare the financial stotements on the going concern basis unless it is inappropriate to presurne that the charitable company will continue in business. The Trustees are responsible for keeping adequate accounting records that are sufficient to show ond explain the charitable cornpany's tronsoctions and disclose with reasonoble occurucy at ony time the financial position of the choritable company and enable them to ensure that the financiol staternents comply with the Componies Act 2006. They are also responsible for sofeguarding the assets of the choritable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The Trustees ure responsible for the mointenance ond integrity of the corporate ond financial informotion included on the charitable company s website. Legislation in the United Kingdom governing the preparation and disserninotion of financial statements moy differ from legislation in other jurisdictions. The Strategic Report and The Financial Review were approved by the Trustees on 8 Mau 2021 ond signed on their behalf by: Jiw Sue Cherrie- Chair of the Board of Trustees. 17 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Independent auditor s report Opinion We have oudited the financiol stoternents of Crohn s ond Colitis UK (the'parent charitable company ) and its subsidiuries (the'group ) for the year ended 31 Decernber 2020 which comprise of the Group Statement of Financial Activities, the Group ond Parent Charitable Company Balance Sh&t, the Group Cash Flow Statement ond notes to the financial staternents, including a surnrnory of signifioont accounting policies. The finonciol reporting framework thot hos been applied in their preporation is opplicoble low ond United Kingdom Accounting Stondords, including Financial Reporting Standord102: The Financiol Reporting Standurd opplicable in the UK ond Republic of Irelond(United Kingdom Generally Accepted Accounting Practice). In our opinion the financial stotements.. give a true and fair view of the state of the group's and porent charitable oornpany's affairs os at 31 December 2019, ond of the group s incorning resources and applicotion of resources, including its income ond expenditure, for the year then ended- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and have been prepared in accordanoe with the requirements of the Companies Act 2006. the Chorities and Trustee Investrnent (Scotland) Act 2005 and regulation 8 of the Charities Accounts (Scotland) Regulotions 2006. Bosis for opinion We conducted our oudit in accordance with International Standards on Auditing (UK) (ISAS (UK)) ond applicoble law. Our responsibilities under those standords are further described in the Auditor s responsibilities for the audit of the financiul statements section of our report. We are independent of the group and parent churitable company in occordance with the ethical requirements that are relevont to our audit of the financiol statements in the UK. including the FRC s Ethical Standard, ond we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe thot the audit evidence we hove obtoined is sufficient and appropriate to provide a bosis for our opinion. Conclusions relating to going concern In auditing the financial stotements, we have concluded thot the trustees use of the going concern bosis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed. we have not identified any material uncertointies reloting to events or conditions thot, individually or collectively, rnoy cast significant doubt on the charitable company s ability to continue as a going concem for a period of ot least twelve months frorn when the financial staternents ore outhorised for issue. Our responsibilities and the responsibilities of the trustees with respect to going concern ore described in the relevant sections of this report. 18 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Other information The other information comprises the informotion included in the trustees onnuol report, other than the financial statements and our auditor s report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information und, except to the extent otherwise explicitly stated in our report, we do not express any form of ossurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is moteriolly inconsistent with the financial stotements or our knowledge obtoined in the audit or otherwise oppeors to be moteriolly misstated. If we identify such moteriol inconsistencies or apparent material rnisstaternents. we ore required to determine whether there is a material misstotement in the finonciol statements or a material misstatement of the other information. If. based on the work we hove performed, we conclude that there is a materiol misstatement of this other information, we are required to report thot foct. We hove nothing to report in this regard. Opinions on other matters prescribed by the Companies Act 2006 In our opinion. based on the work undertaken in the course of the audit.. the information given in the trustees report (incorporoting the strotegic report ond the directors report) for the finonciol yeor for which the finoncial statements are prepored is consistent with the financial statements., and the strategic report has been prepared in accordance with opplicable legal requirements. Matters on which we are required to report by exception In the light of our knowledge and understanding of the group ond parent choritable company and its environment obtoined in the course of the audit, we hove not identified material misstutements in the strategic report and the directors report. We hove nothing to report in respect of the following motters in relation to which the Companies Act 2006 and the Charities Accounts (Scotland) Regulotions 2006 requires us to report to you if, in our opinion.. odequate and proper accounting records have not been kept by the parent charitable company, or returns adequate for our oudit have not been received from branches not visited by us. or the parent charitoble company s financial statements are not in agreement with the occounting records ond returns- or certain disclosures of directors remunerotion specified by law ore not made., or we have not received all the informotion and explonotions we require for our audit. 19 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Responsibilities of trustees As explained more fully in the trustees responsibilities staternent, the trustees (who are olso the directors of the choritable company for the purposes of compony low) ore responsible for the preparation of the finonciol stutements and for being satisfied that they give o true and foir view, and for such internol control as tFE trustees determine is necessary to enable the preparation of financial statements that ore free from moteriol misstatement, whether due to fraud or error. In preparing the financiol statements, the trustees are responsible for assessing the group's and parent choritable company s ability to continue as o going concern. disclosing. as applicable, matters related to going concern ond using the going concern bosis of accounting unless the trustees either intend to liquidote the group or the parent charitable company or to cease operations, or have no reolistic alternotive but to do so. Auditor s responsibilities for the audit of the finoncial statements We hove been appointed as auditor under section 44(1)(c) of the Charities and Trustee Investrnent (Scotlond) Act 2005 and under the Companies Act 2006 und report in occordance with regulations made under those Acts. Our objectives ore to obtain reosonuble assurance about whether the financial statements as a whole are free frorn moteriol misstotement. whether due to fraud or error, ond to issue on auditor s report that includes our opinion. Reusonable assurunce is o high level of assurance, but is not a guuruntee that on oudit conducted in occordance with ISAS (UK) will alwuys detect a moterial misstaternent when it exists. Misstatements cun orise from fraud or error ond are considered material if. individually or in the aggregate, they could reosonobly be expected to influence the economic decisions of users token on the bosis of these financial stotement& A further description of our responsibilities for the audit of the financial stotements is located on the Finoncial Reporting Council s website at: www.frc.org.uk/auditorsresponsibilities. This description forms port of our auditor s report. Extent to which the audit was considered capable of detecting irregulorities, including fraud Irregularities, including fruud, are instances of non-compliunce with luws und regulotions. We design procedures in line with our responsibilities, outlined above, to detect moteriol misstotements in respect of irregularities. including fraud. The extent to which our procedures ore copable of detecting irregularities, including fraud is detailed below.. We gained on understanding of the legol and regulatory framework applicable to the Charitable Group and the sector in which it operates and considered the risk of the Choritable Group not complying with the opplicable laws ond regulations including fraud in particular those that could have a material irnpuct on the financial stoternents. This included those regulotions directly related to the finoncial statements, including financial reporting. tax legislotion and distributoble profits. In relation to the operations of the Charitable Group this included compliance with the Charities Act and SORP 2019, GDPR, employment law, safeguarding and health & safety. The risks were discussed with the audit teorn and we remained alert to ony indications of non- compliance throughout the audit. We carried out specific procedures to address the risks identified. These included the following.. 20 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Reviewing rninutes of Board Meetings. reviewing ony correspondence with the Charity Cornrnission, agreeing the finoncial statement disclosures to underlying supporting documentation, enquiries of monogement and officers of the Charitable Group and a review of the risk management processes and procedures in place including o review of the risk register maintoined by the charitable group. We hove also reviewed the procedures in ploce for the reporting of anu incidents to the Trustee Board including serious incident reporting of these matters as necessary with the Charity Cornmission. Management override.. To address the risk of monogement override of controls, we carried out testing ofjournal entries ond other odjustments for appropriateness. We reviewed systems and procedures to identify potentiol areas of managernent override risk und evaluated the business rationole of significont tronsoctions to identify large or unusual transactions. We reviewed key authorisation procedures and decision moking processes for any unusual or one-off transactions. We olso assessed management bios in relation to the accounting policies adopted and in determining significant occounting estimates. including treatment of legacies ond grant incorne. und the omortisution rutes of intongible assets. Because of the inherent limitations of on audiL there is a risk that we will not detect oll irregulorities. including those leading to u materiol misstatement in the finonciol statements or non-complionce with regulation. This risk increases the more thot complionce with a law or regulation is rernoved from the events ond transactions reflected in the financial statements. as we will be less likely to becorne oware of instances of non-complionce. The risk is olso greater regarding irregulorities occurring due to fruud rather than error, os froud involves intentional concealment. forgery. collusioTL omission or misrepresentation. Use of our report This report is mode solely to the chorituble cornpony s members. as a body, in occordance with Chapter 3 of Port16 of the Companies Act 2006, and to the choritoble company s trustees, os a body. in accordonce with Regulotion10 of the Charities Accounts (Scotlond) Regulations 2006. Our oudit work has been undertaken so that we might stute to the charitable company s members and its trustees those matters we ore required to stote to them in an auditor s report and for no other purpose. To the fullest extent permitted by law. we do not accept or assume responsibility to onyone other than the churituble compony and the charitable cornpany's membersos a body and the charitable company s trustees as a body. for our audit work, for this report, or for the opinions we have formed. I n&afj Helena Wilkinson Bsc FCA DChA (Senior Statutory Auditor) For ond on behalf of Price Boiley LLP Chartered Accountants Statutory Auditors 3rd Floor, 24 Old Bond St, Mayfair, London W1S 4AP Annual Report and Financial Statements 2020 Crohn's and Colitis UK Financial statements Crohn's and Colitis UK Consolidoted Stotement of Financial Activities Including Income and Expenditure Account fir the year ended 31 December 2020 UnTe5trict•J Totol fvnds 2020 Totol fuThJs lintydesignot furMlsnote22) Restricted funds Note In(x)me: Dtsnotims 0ndI￿o¢le& lhorit0￿Èott1VIt1eS 1,536,790 668,781 1.503571 34,743 249,949 376,931 9,004 298B81 1,913,721 671,785 1.802,458 34,743 249,949 2,163,605 674,212 3.￿&828 53,538 2,290 InvÈgtrÉnts Other Totol thme 3,993.840 684,818 4.87&856 6.247.4TJ Expenditure.. Roising funds ttrittsble aclivlties.. 1,569,016 159,9601 1,509,056 2,119,944 GTaniTwking Supporter krvicÈg Morketingttnd Commnlcoiiong Polity, Putlic Afffoirs ond Compoigns NeiwoTks& Volunteering MembÈrship costs 1,002 397,034 372,492 567,482 244.017 427,284 167.4471 ?92,304 81,040 189279 12,4 166.445) 689,338 453,532 756,861 256.450 427,264 1.131,1 893,286 8￿,278 960,652 422.303 646,134 Totolexp*difurÈ 3,578,307 447.749 4.026.058 7.012.T28 Netincome/lexpÈrrtlirurÈl bÉfore invtttmÈni goins/lbssesl Goins/liossÈsl on inveshnÈnts 41&533 237,087 652,800 1765,2551 17 134,3081 134,3081 88,789 Netincome/lexpenditUTe) 381.225 237.067 618.292 1676.4661 Trttnsfers t*tweÉnfunds 15 20,015 120,0151 NÈtmo¥emenrthfunds 401240 211.052 S￿29? {676.466) R￿nCI￿allOnQf furds.. Totolfunds brought forward 1,935,244 135,042 2,070,286 2,746,752 Totolfunds (*JkTied forward 2.336,484 352,094 2.688,578 2.070,286 Note 22 Note 23 The Srormnt of Finoncial Aciivities Includes oll goins ond losses inthe yeaTond ther¢foreo stotewl of totol recognised gains ond losses hos noi beÈn preptsr￿. Allof the oboveomunts totoniinuingaciivitiÈs. The nel surplus of the ChoTirotleCw)pony for Ih¢yeor wos £618.29312019 deficii £676.4661. 22 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Crohn's and Colitis UK Balance sheets ot 31 December 2020 Broup Chttrknbiecompony 2020 Note 2020 FvKdassets longible assets Tangible assets vestrnent 16 16 17 457889 385.581 1,092.384 577,335 505,610 1,088,789 457889 385,581 1,092.385 577.S35 505,610 1,088,790 Total Fixed Assets 1,935,854 2,171,734 1,931855 2,171,735 CurrEnt assets Debtors Cosh ot LKJnk and inhand 18 19 705,￿6 2,041,663 884,717 1,990,704 708,381 1,928,003 917,004 1,919899 Total Current Assets 2,747,0 2,875,421 2,636,384 2,836,903 LKibiliti£s Creditors.. arn￿ntS lolling due withinone yeur 20 11,485,539) 12,171,301) 11.374,8651 12,132,784) Net current ossEts 1,261,520 704,120 1,261,519 704,119 Totttlttssets less cuYrÈntknobilities 3,197,374 2,875,854 3,197,374 2,875,854 CTEditors'. orTwxJnts lolling due ofterone year 20 1458,7961 150.0001 1755,5681 150,0001 I4￿,796) 150,0001 1755,5681 Provisions for liabilities 21 150.0001 Total net assets 2,688,578 2.070,286 2,688,578 2.070,286 Thefund5 of thechaTity Unrestricted funds DESignatEd funds held nationally DESignatEd funds held by Networks General Reserve Fund held notionollu 22 843,470 202,929 1,290,085 S77,￿6 361,362 996.546 843,470 202,929 1,290,085 S77,￿6 361,362 996.546 Total unTestriCt￿IfuTXIS 2,336,484 1,935,244 2,336,484 1,935,244 Restricted funds Held nationoll 23 352,094 135,042 352,094 15042 T0talTestrict￿fuTNIS 352.094 135,042 352,094 135,042 Total chority funds 2,688,578 2.070,286 2,688,578 2.070,286 The QCCOUllts, which comprise the consolidoted statement ol linancioloctivities, the balancesheets and the related notES, were outhorised lor issue bu the Board of TrustEES on 8th Mou 2021 by.. J￿Q )rnpony Nunther.. English Charity NumEÈr'. Scottish (hority Number.. 05973370 01117148 SC038632 Sue Cherrie. Choir * Grth Cu￿ent ond prior yeDfEnds. CopitttlistttiononddeprÈcittt￿rt0f tttr¥JthlÉ ttrd lntonoib￿r￿&1u$Sets All fixed assets are initiolly recorded ot cost. Tr2preciation is colculated soos to writeoll the cost ol unasset, less its estirnated rEsiduol viJluE, over the useful econonryc lileol thot asSEt os follows.. Letssehold impTovÈrnents Fixtures and fittings SoftworÈdevelopmÈnt >mputer equipment pital comrrutment5 ore disclosed os atthe yeurEnd. stroight line over rhe lÉose per 25% perannumstraight line 20% per ortnumsrroight line 33% perannumstraight line QSSEt inve5ttnents Fixed asset investrnent5 UTE Includ￿ at rrnrket volueat the bolonce shEEt dote.Any gainor Ioss on revaluotion is token tothE SOFA. Pensioncontributions The chorily mokÈg tontribulions forÈmployeÈs too group pergortol pension sthemÈ. This ig o defined tontributlon scheffÉ to which theAssociatIonn￿kes ernployers contributions ol either 5% or 8% 01 gross poy. Funds AccountiNJ Funds held by the charity are.. Unrestricted general funds- theseore funds which can used in accordance with the choritableobjECts at the discretion of thÈTrust*s. Designated funds- these orelunds set oside by the Trustees out ol unrestricted ￿neraL funds lor specific fijturepurposesin accoi08nce with thedevdopmentplansof theorg&nisation 8nd to enab￿ thecompletion ofexisting projects. Resriicted funds- these8rÈ funds th8rtsn otilybeused forpartpcularrÈsfricr&l puFposes wirhin theobjettsof rhech8rity. RestrictionsarisewhenspecifieL(bythe donororwhen funds&reraisedforparticulsrpurpose& These funds ore further divided between those held Nolionolly and those held by LocolNetworks. Further explanation olthE noture and purposeol eoch fund Is Included in the notes to theoccounts. OpeTating leases Rentols opplicobletooperoting leoses where substantiolly oll the l￿nefitS and risks of ownership re￿Inwith thelEssofaTE charged tothe SOFAona stroight line bosis os they arise. Ftnontiol Instruments The chorily only hos linanciolossets and financial liabilitlES ol a kind thatwalily as basic linonciol instrurnents. Bosicfinanciol instruments ttre irtitittlly rewnised ot trttngortim voluÉ ond subsequently meogured ttt their Settle￿nt volue, which Ls ot COSL with the exception ol.. hvesttnents ore trEasured at their lairvolue as at the balonce sheetdate,. Fixed ogsÉts ttre ￿Sured ot tost less dÉpreciDtion ond arnrtisotion-, ond The invegtmenrs note 17 deitsils the historic cost of the InvÉstmÈnts ttnd the unreDli*Éd golns tottrriveot theirfoir vttlue. Judgernents and key sOuT￿s ol unI￿rtaIntY NojudprnÉnts lopart fromthose Involvingestimoresl have mode in the prrtess of opplyingthe othvÉ otcounting polities. The key IJSSUTTWtions conceming thefuture and key sources Olestin￿tIOn uncertainty ot the key reporting dotethat hovea 51gnilicant risk ol cousinga rmteriolodjustrrEnt to the carryinganwunt5 01 assets ond liabilities within the next linoncial yeor IntludÉ'. Estirnotion ol theuseluleconorruc lifeol buildings, furniture ond ollice equiprnentond IT equiprnent. 26 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Crohn's and Colitis UK Notes to the Accounts for the uear ended 31 De￿rnber 2020 (continued) Donotions ar￿ IwJacies 2020 2019 tk)nations Iromtnetnbers 190,248 31,106 1,357,105 1,578,459 167,732 81,627 1,197,999 1,447,358 tkjnotions to Local NEtWOTks Otherdonations (in tnemriarTr poyroll, gilt oidl LwJaciES Research Unrestricted 5,000 330,262 52,682 663,565 1,913,721 2,163,605 Incorne fvorn other trading octi¥itiES 2020 2019 NationolfundToising Locol network5 lundroising Externalturnover ol trading subsidiory 1,603,117 3,149,228 77,621 126,979 199,341 1,802,4&8 3,353,828 Investment in(x)meand inteTest 2020 2019 Other Interest.. Charity Trading subsidiory 34,743 53,536 34,743 53,538 Income fvom choritobieoctivities 2020 2019 Subscriptions 677,785 674,212 677,785 674,212 ExperKlitureon choritobieactivities Direct staff (x)sts D￿eCt otheT (x)sts Support costs Total Total 2020 2019 Costol generoting funds InotE 91 677,185 467,334 364,537 1,509,056 2,119,944 Granttnaking InotE11) Supporter Services Marketing and Cotntnunicotions Policy, Public Alloirs & QJmpoigns Networks & volunteering Membership costs 144,659 545,103 353,084 441,721 170,832 129,751 1211,3541 42,858 3,830 170,259 23,334 193,465 250 101,377 96,618 144,881 62,284 104,048 166,4451 689,338 453,532 756,861 256,450 427,264 1,131,133 893,286 839.276 960,652 422,303 646,134 2,462,335 689,726 873,995 4,026.056 7,012,728 Inote 7) Inote 81 27 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Crohn's and Colitis UK Notes to the Accounts for the uear ended 31 December 2020 (continued) ExpÈnditurÈonthDYit0b￿uc1i¥￿tks[r￿jnt￿ts Dlrect stuff sts Dlrect other costs pport rx)sts Totol 2019 The tomporotive from last year LI detttiled belDW thstof gÈneroting funds oritttblèttctivities Grontmttkirtg Supporter Services marketing ond Cortwnunicotions Polity, Publit Affoirs & Compoigns NÈiworks & vdunieering memk￿r$hLp costs 828,153 1,158,057 335,734 2,119,944 152,751 572,613 520,575 430,124 246,817 187,951 2,738,784 978,382 187,916 174.260 385,197 101,891 344,122 3,327,825 1,131,133 893,286 839,276 960,852 422,303 646,134 7,012,728 132,757 144,441 145,331 73,795 114,061 946,119 Stoff costs 2020 2019 Wtt￿$ ond sttlories Sociol security costs Pension costs 2,130,782 207,509 124,063 2.462.334 2,362,678 235,025 141,081 2,738,784 Theoveroge numtrÈr Df staff ond rhe ttllttotlon of thelT t1￿￿ wos.. oritttblÈoctivities tlirect Support Cogt of gÈnerDting [￿ndS 2020 2019 41 13 16 49 12 17 70 78 At the start Df the yeor the Chttrify hod 1000 vdunteers OCTOSS the UK, howevertheiT ttbility iodtstheir role orttctivities wos sevÉrÈly Impotted by Covid-19 with r[￿$t Dctivitieg hoving lobe pttused.ThDse who wÉrestillttcrivÉ continued to provide owttrenegs, fundroisin9 and informoiioft shoring. Volunteers olso supported theehority on o voriety off iftrernol ponels,tts vwell os in the mdio, os Trustees, ortd providingthrEe separate Helpline seivices.wealsopiloted virtuol socioland Education event5 thot were hosted by ourvolunteers. Ktrj monttg#neftt (￿m￿n$￿ttin Dperational rnonogementol the Charity is overseenby the Chief ExecutlVE, supported Senior Leodership Teamthal numbered 7at the stttrtof the yettr but was redutÉd 105 Dt the Ènd of Ihe yettrl2019.. 61. Total remunÉrotion, including pension costs in 2020 was TwomembÈrs of stofffwerÉ poid rnre Ihon£70,000 ttrtd legs thon £80,000 in thÈyettr12019.. two). Three mÈmbÈrs off stDff were poid more thon £60,000 ond less thttft QO,000 in the yeor12019.- threel. Pension toftlribulions in respett of these stoff memt￿rg totollÉd f26,83612019.. £25,8971. ring the year the surnol £26,839 terminolion poyrnents WEre paid outto ll rnernbers olstafl whosecontrocts WEreterrTwnatEd by the ority,ond poid in full in the yettr whenthÈstoff left. pwrtcosts 2020 2019 OrhÈr stofff relDtÈd tosts PremisÉs costs OFfice operoting tosts Sovemttnce tosts 49,582 349,513 456,042 18,860 873,997 89,517 2,003 470,570 31,778 9￿,888 htluded In support costs ore thÈfollDwing'. Arnortisotionol intangiblelixed asset5 Dep￿CLot10n0f tongible fixed ossets Property rentol Dnd servitÉ chargÈs 143.484 120,029 277,418 105,100 121,081 289,889 Supportcosis ore 011￿0[ed Dcross the ttctivity oretss Df the Chority onthe thsis of direct staff rime relttted tDtheactivify 28 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Crohn's and Colitis UK Notes to the Accounts for the uear ended 31 December 2020 (continued) 8a Netinwming/loutgoing) rEsourc85 for theyeor- Group 2020 2019 This is stoted olter chorging'.- Depreciotion ond amortisation Operoting Leoses Auditors remuneration Crohns & Colitis UK Auditors rEmunerotion- NACC Merchondise Ltd 263513 288,958 10.550 2,525 226.181 288,958 10.100 2,400 Di￿t costof genErat￿g fuTKIs 2020 2019 Externol costs of troding subsidiary Notionul lundroising direct costs Local Networks fundroising 100,040 1,406,491 1.310 110,773 1,980,061 29,110 1.507.841 2,119,944 10 Troding subsid￿ry The charity has o wholly owned trading subsidiary NACC Merchondise Limited,0 company incorporated in Englond & Wales Reo. no. 03297441. The componu sells (hristtTllS cards and other pr(Mlucts. The cornpany tronsfers its taxoNe profits to the chority. A Sum￿rY ol the troding results of the company is shown below. Audited accounts have been liled with the Registrar ol Companies. 2020 2019 Profitond k)ss account Turnover Cost ol soles 199,341 1105,8611 126.979 1106.0301 Gross profit AdnTrnistrative expenses Interest receIva￿e Net Prolit/llossI on ordinory activities Atnount gilt aided to Crohns & thlitis UK Net Profit lor the yeor Retoined profit brought forward 93,480 110,442) 20,949 19,7431 83038 (810381 11,208 (11,2081 Retained profit carried forward 116ront moking expenditure 2020 2019 Support gronts Medicol research Livingwith IBD reseorch IBD Health Services Reseorch portnership grants Other- Lwal Gronts rTh]de by NEtworks Gronts written bock in yeor 15.254 469,125 194,603 232,3n 70.000 27,916 14S700 176,861) 13&000) 3,994 1206.919) 1168.886) 140,474 128,412) 1,009,269 121B64 1.lJ,133 Direct costs ol grant making process Researchgronts Gronts ore awarded by Crohns & Colitis UK Research G)wuttees tofund reseorch projects thot have keen approved by peer review. GrontS tnoy be lor equiprrEnt, Consun￿)bleS or solaries. Crohns & Colitis UK does not wntribute tothe overheod costs ol such institutions. Due tothe pandemic this yeor, the allocation ol new research grants wos poused. During2020 there were a number of grants thot were underutilised ornounting too writebock of £1206,9191 (2019 £150,57911 29 Annual Report and Financial Ststements 2020 Crohn's and Colitis UK Crohn's and Colitis UK Notes to the Accounts for the uear ended 31 December 2020 (continued) 11 Grant making expeTKliture (continu￿) 2020 2019 m￿lICalrEs￿Tth University ol thnthrid Royal Liverpool St Morks H￿pitaL University Cdlege London Kings College London 14S700 87,164 18.150 179,775 184,036 469,125 145,700 OthergTants Locol Networks roised funds lor local projects towhich grants totolling £3.99412019 £27.9161 were mode. 2.020 2019 Sociol& Psychok>gicolRe5eaTch 117,942 76,661 Univer51ty ol Traditionijl tnedicine 176,6611 176.6611 194.603 IBD HeolthSeTviixGronts Addenbrookes Hospitol Cortl)ridge Queen flory s 117,378 114,993 232,371 Research Pothership grants Royal College ol Surgeons c￿lIac UK (35,0001 35,000 35,000 70,000 135,000 12 GovEmorllxdirectix)sts 2.020 2019 Auditors rEmunerotion- current yeor Legal ond professionol expenses Meetings and trustee expenses Other governonce costs 14,225 70 661 3,904 18.860 12,500 6,500 12,778 .778 13 Transoctions withTTUStees No Trustee received any reTT￿nerotionfo[ their services os IJ Trustee. A totol ol £10012019- 13,7601 was reinthursed to or poid on LEholf of 212019.. 91 Trustees in respect ol trovellingexpenses and other costs incurred in carrying out thEir respon51bilities os Trustees. 14 Operatuw l￿Se5 At 31 Decernber 2020 thegroup had commitrnents under non-concellaNelEases as lollows'.- E9ulpTn￿t Londand Buildings Equ￿)ment Lar￿ and Buildings 2020 2020 2019 2019 Amounts poyaNe within1 yeor Amounts poyaLIE LEtween ? and 5 yeors 7,592 1,872 9.464 288,958 529,755 818.713 7,592 6,464 14,056 288,958 818.713 1.107,671 Totol operating leoseexpenditure recognised in in the SOFA omunted to £277,41812019.. £289,889) 30 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Crohn s and Colitis UK Notes to the Accounts for the uear ended 31 December 2020 (continued) Transfers Tronsfers ore modÈfor tt voriety Df reosons, between typesof funds Dnd between Not￿￿oI￿nd Ltthl Networks, the note bÈlow dlusirttres th#È'. unrestr￿ted Funds De?￿nat& FuThls R¢%trict• FuThls Total NtttiDnDI Tronsf¢rs ￿tween notionolfunds'.- Tangible fixed ossets mov¢Twnt in netbook voluel11 Intongitlefixed osseis rwvement Innet bwk volue121 Network funds inexcess of 3yÈtsrpdity131 Networks from restricted todesignated141 Totolfurds 191.755 1457.8891 158,453 1191.7551 457B89 I158,4￿) 20.015 127.n6 120.0151 120.0151 1107.7011 Inoie 221 1480.6401 Inote 221 1327.3551 Inote 231 807,995 2019 transfers between notionalfunds Notes 1.Th¢netn￿v?T￿ntQf rongiblefixed ossetoddirions ond disposols duringthe yeor 2.Th¢nei movemenrof Iniongibl¢fixed ossei oddirions ond disposols during Ihe year 3.Releose of nerwork Funds relotingro Ihosenetfunds Inex¢essof th¢3 yeor pLIIcy 4.The gurplus ffrDmihe Networks ottivities in rhÈyÈttr, In line with rheirrelevttnt per￿SSionS, ￿ reclossed 0$ dÈsignatÈd rtttherthon restricted. IntttrvJib1Èf￿dttsgets All ossels hekl foru5¢by the ChoTity Charity Software dÈvdDpment Total Cost Broughtftrwttrd1 Jttnuory 2020 Additions in yÈor Disposals 699,171 24,038 699,171 24,038 Carried forword ot 31 Decenkner 2020 723209 723209 Amorti￿tI)n Broughi fDrwttrd1 Jttnuory 2020 Chor9e For rheyeor Disposols Carried forword ot 31 Decenkner 2020 121,836 14&484 121,836 143.484 26&320 26&320 Net book voiue Ar￿$1 Oecember 2020 457B89 571.3 457B89 571.335 ArJst December 2019 Group Cost Brou9hrforward1 January 2020 Additions In yeor Disposttls Carried foTWQTd ot 31 Decenkner 2020 699,171 24.038 699.171 24.038 723209 723209 Arnortusotun Broughi fDrwttrd1 Jttnuory 2020 ChorgÈ lor theyÈor Disposols Corried forword ot 31 Decenkner 2020 Net book voiue Ai 31$1 [￿ternber 2020 121,836 143,484 121,838 143,484 26&320 26&320 457,889 457,889 Ar￿st tkcember 2019 577.3 571.335 Ar31 Decentsr2020 rhere wwenocapitolcorMiiThnt$12019.. £282331 31 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Crohn's and Colitis UK Notes to the Accounts for the uear ended 31 December 2020 (continued) 16 Tongti)lefvKql ossets (1x>ntinu￿) All assets held lor use by the Choiity Charity LEasehold Improvements FiKtUTes and Fittings Comput Equipment Total Cost Brought forward1Jonuary 2020 Additions Disposals 461,291 282,412 147,219 890,922 1192,1951 1192,1951 Carried foTward ot 31 December 2020 461,291 90,217 147,219 698,727 Depreciotion Brought forward ljanuary 2020 Charge lor the year Disposals 75,973 48,142 239,429 22,814 1192,1951 69,910 49,073 38S312 120,029 1192,1951 Carried foTward ot 31 December 2020 124,115 70,048 118,983 313,146 NEtbook value At 31st DecemLEr 2020 337,177 20,169 28,236 385,581 At 31st December 2019 385,318 42,983 77.309 505,610 Group Leasehold Improvements FiKtUTes and Fittings ComputeT Equipment Total Cost Brought forward1Jonuary 2020 Additions Disposals 461,291 282,412 147,219 890,922 192,195 192,195 Carried foTward ot 31 December 2020 461,291 90,217 147,219 698,727 DEPTeciotion Brought lorword l Januory 2020 Charge lor the year Disposals 75,973 48,142 239.429 22,814 1192,1951 69,910 49,073 385.M2 120,029 192,195 Carried forward at 31 December 2020 124.115 70.048 118.983 3.146 NEtbook volue At 31st DecemLEr 2020 337,177 20,169 28,236 385,581 At 31st December 2019 385.318 42.983 77.309 505,610 *Group repr￿entS the consolidotion of the Chority with its tradingcotvpany At 31 DEcember 2020 there arE CQPltal comrnitrnents ol £0 (2019.. £0) 32 Annual Report and Financial Statements 2020 Crohn's and Colitis UK Crohn's and Colitis UK Notes to the Accounts for the uear ended 31 December 2020 (continued) Group 17 Investments arity 2020 2019 2020 2019 Morketvalueof investments ot1 Jonuary 2020 AcqLUSitions otcost Disposols/proce2ds R￿lised goins/llossesl on investments Unreolised gains/(losses)oninvestments Morket volueol iwtments ot 31 Docember2020 1,088,789 s(Ki,000 1462,0981 137,8931 3585 1,088,789 s(Ki,000 1462,0981 127,8931 3,585 1,(￿,000 1,000,C 88,789 88,789 1,092,384 1,088,789 1,092,284 1,088,789 InApri12019, rhechorily invosied £1,ffl0,OOOinon Investment FU￿ with COIF, the MorketVolueot31.12.19 wos É1,088,789. During 2020on1 April the charity d￿posed01 £499,990ato loss of £37,892,ondthenreinvested Q250,(KiO on13 August ond onother £250,OOOon12 November. Thechoritoblecomponys bo[oMeSh￿t1nC1Ud￿ o £1 invosrment inNACC Merchondise Ltdlsee note101. 18 Debtors Graup ChaTity 2020 2019 2020 2019 Ail amounts foll due within one yeor jlonco withtroding subsidiory -epoyments Tox recovoroblo Othwdebtors Accrued income 44,996 327,299 125,618 13,898 196.5r3 372,295 125,618 5263 202,222 35,864 143,734 81,956 337,163 35,864 143,734 114,947 336,459 705,396 884,717 708,382 917.￿4 19 Analysis of cosh at bonk ond in hond Group arity 2020 2019 2020 2019 CuTTent a(￿OUntS ond cosh bolo Inter0St-b￿1lng oceount bolo Local Networks 1,￿2,380 850,281 98,922 s￿,903 1,192,897 6,904 978,720 850,381 98,922 430,098 1,192,897 296, 2,041,883 1,990,704 1,928,003 1,919,899 20 Creditors.. omoLJnts failing due within one WT Group enarity 2020 2019 2020 2019 Unpaid boloncesof Teseorchgronts Trode creditors cial s{rurit￿ ord othertaxes Accruols orddelorred income 972,974 1S5,144 58,896 8,525 1,361,103 327,883 7,141 411,174 9￿,974 44,469 58,896 298,526 1,361,103 289,365 7,141 411, 1,485,539 2.17.301 1,374,865 2.132,784 tkferred income reconciliotion aalonce broughtfoDword Amounr rocogrlls•J inthe yeor Amount defeTTed inthe yeor loncecorried loiword 1￿,747 1￿,747 1￿,747 129,747 Creditors.. omoLJnts failing due ofteT one yeor Group arity 2020 2019 2020 2019 Unpaid bolonces of reseorthlunds 458,796 755,568 458,796 755,568 33 Annual Report and Financial Statements 2020 Crohn's & Colitis UK Crohn's and Colitis UK Notes to the Accounts for the uear ended 31 Decernber 2020 (continued) Y2 UnTestiirtd funds 2020 2020 BTought forword Income Exp&)dibJre Tran$fw$ forward D￿I9￿￿tedfUndS= TorLg￿1e fLyed assets lol 5Th,336 1191.7551 457.889 1158.4331 385,581 457.￿9 202.929 NetLyorks rÈioinÈdfundg 361.362 DesiwatÉxl totol 8.698 107.701 1.046.399 Other unrestrictsd funds Generol Reserve Fund held Nationally Ncn charitabletradiFLgfuFLds 99e.54e 2.794.499 2 412 274 187,6eei 1,290,085 199 241 199.341 998.548 3.993.840 3.8￿.815 187.6881 1.290.085 Totol l935.244 3.993.840 3.612615 20.OE 2.336.484 {0) A fund Ismaintained thotrepresents thenetboJk value of tong￿LefL￿ed ossets In so far os these funds aTenot ovoiloEle for wrrnediate use. Ib) A fund Is maintained thotTepTesents thenetboJk value of ntangblefixed assets ￿ so far as thEse funds QTen0tavai￿bIE f immediareuse. {c) The Trustees haveagreed thotaccumU￿tgA surpluses from the NetrwoTks should desiwated for future use by Networks.NetWOTks are requwed toutilise thesefunds widiin three yeor£ ￿ which th￿j arereported. 20 2019 UnrE5triGted hjnds BTought fDrwurd IncoTne ExP￿ditUrE Trun51￿5 fDrwurd Designated funds Fixed Assets 2eo.966 296.370 5Tr.336 Prq)Erty Fund 331,645 1331.6451 1286.0271 1227.6981 CRM 2e6.027 Neti¥orks retoinedfunds 61E.S41 159.242 78.729 261.262 tksigioted total l511,179 159,248 1480,e401 938,698 Olh6T unre5trictEdfund5 1.SE.627 5.198.05e 126.981 5.236.499 126.981 1480,6401 996.546 Ncn charitabletTodingfunds 1.5E.627 5.325.039 5.383.480 1480.6401 99&546 Total 1701161 5,484,287 5,441209 1807,9951 1,935,244 34 Annual Report and Financial Statements 2020 Crohn's & Colitis UK Crohn's and Colitis UK Notes to the Accounts for the uear ended 31 December 2020 (continued) 2020 Brought forword 2020 23 Resiricted funts Qjrried forword Incotne ExppnditUT8 Tronsfers Notiond Regeorch Young pEvplEond farniliE5 LondonWolk- CoTporote I￿￿me Help11￿8 IBD NursES ** airllcal Conn Potieni InforYNItio IBD REgistEr InThEirShoeg Richord Drisu>ll IBDfdlowship SpDtlight IBD Poost Not EvEry DisabilityisVi5ibl8 Property Woleg Project PEPProgTatnrn HEulthSeTViCE D￿0Pr￿gnt Gut React ItTtskesGuts Pot*nr&Public hvolvment Rllnthe nightfundroisingevent NtstionalLottery Helplin¢yront Q*rfiddWEStonlBD NursEsgTant Netwoths la) (bl .152 198.692) 1.340 159 180.653 142.355) 121 59,888 9219 1.236 149 19.087 6B31 78.￿7 188.844 1.340 159 20fft5 31.76 Id) 160.518 159.293) 500 14.778 In 13.138 46.750 9220 26.100 (h) 24.864 149 19.087 20.￿ 20.085 14.074 53.246 Irn) 1ll.218 In) lol Ipl 29 11.764 15.000 29 110.0001 15.000 52.608 S9999 8ECM) 2250 49S99 32.74 11.093 52.608 10.000 2250 35(M) lu) 10.0 42.286 75.000 31.106 Iw) 120.0131 Totd restricied funds 135.042 684.816 447.749 120.0151 352.094 * WherEeYpEnditureonopoTllcularFund EXCEEdsIncor￿.￿ Ironslerhas beenrwdEto/frorn UnrEstricted lurds. lal R￿arCh- Medi(￿1 ond Litring withlBDregeorchgronts fundedby individuol supporters Ibl Youry p￿p1£￿￿dfOrniI1eS- fundsrEcaved forE¥Ents and supportof yDungErpwpleondfotruli Icl LondonWolk- corpoTatslurKling ￿1VedinsUpPortof th?LDndonWolksupportWEVEnt Idl Help11￿5- fundsrec&vEd to supporrtherunningandstoffiw of theChorityshdpliT*S lel IBD NursES-funding tosupportthEOduw￿Tne￿tQlt￿E IBDStondard rEgarding prDvisionond occessto IBD NursEs In ainical CDnnECt- fU￿S to supwrtthedw*loprnEntof o dEsignot& orEoof thEw&sitEfDrHEolthCorEProfes5ionols 191 Potieni Informoiion- hJNtsrecaved 10 gupporrthere-printiw ond dL%iribLJtionof potientliterotureprovitslto hospitals Ihl IBD REgistEr-to hElp lurKlo newCEOof then￿[Y incorporatsdlBDrE9iStty lil InTharShDES- tD hEIp WyDn8undErstandwhotsuffwErsof thEd1s￿se￿￿ri8t ljl RichordDriswll- IBD Fdlowship Ikl Sp)tlight- to iwprovE urdErstondiry of IBD atnoryst GPs.andtoproduceatoolkit ond6xlucationol tnatErioIs (Il IBD Boost- uti115Edigitalplattorrns lo irnport Potiert Rewrt& Outcornes MEosufwiEntdatainto IhelBD REg15try Iml Not Every D￿abiLitY is ViS￿le- chongeoccwsibleioilei SIgr￿get0 he￿ roiseowore￿s In) WolEs PrDj6EI- todEvdop&iTnplEwentthEWalEs BIuepTintfDrlBD Cur lol PotiEnl EducotionProgrornme- lo TunpatienteducotionprogrornTneloEtnpowerpepl8offEct￿lb￿ Crohns orcolitis to [r¥I￿ged1591s Ipl H￿IthServi￿ D￿￿10pment- devdopiTYJ bellerhwJthservic* fforpwpleliv1ngwithcroh￿ 0ndorul(￿r0￿Vè Iql R￿CtiOn- the HeolthDoto REseorch UK Digital InmvotionHub lor IBDcoTnbining data Irl ItTokesGutg- compaignto hdpsociety understondthotlBD 18anirivis￿1ÈiI[￿S ond wopleshould spgnkoutand noisufferinsilen Isl Potieni ondpublic involvemeni- to d￿elOp PPI troining Modul￿ withoims to incrwtsethe kY>gitiveimpaci PPI hog inreseorrAproj￿s It) RunthErught-fundraisingEvent lul NatIOT￿l Lottery- Helpli￿gronl-T0TUnTr1tiO￿l hdplinef0rp￿pIÈ1Ivlng￿1thcrOhTrSoThIcOL1tI$ Iv) IkrfiddWegton- IBD Nurg* gront Iwl Nthvork octivily rnovwJlrotnrE5trictEdto dEsignotE ** Di[￿l rnorkEtingcosts forthelBD Nurses appeolwos trEot& os restrictEdExpEnditurein3)19buthasbwrEclo55Ed osunrestrict xpendilurEin2020which 15 why thEfeisTwoliverestrictEdexpEnditurEinthE yEur. 35 Annual Report and Financial Statements 2020 Crohn's & Colitis UK Crohn's and Colitis UK Notes to the Accounts for the uear ended 31 December 2020 (continued) 2019 Broughi forword 2019 Restricied funds rAJrried forword Income Eynthiture TTansfeTS Noiionol R￿￿r(￿ Wdfore- supwngrants Publicollo￿ Vidws Potieni Mop/lBD Compoyllon Young peopl&andfomdi LondonWolk- CorporotelNxme la) 358.594 20B65 12.(ml 1.142,&9 35h13 S.MO 309 11.726 1331 15.174 130.685 784.0 14.648 7.000 13.066 1.4 35.81 162.401 1240 159 20.635 31.716 121 13.138 Id) IBD Nurs Clinicol Corv Potieni InfoTrMtion IBD R￿ISter Potieni Eroogement InTh&rSloes RichardDr￿(￿lLlBOfelk>wshLp Spotlighi IBD Boost Volunt*rDeveloprfteni Potieni EmpoWer￿n[GUIde 82.856 Ih) 1.389 1.389 1&107 318 37.663 13263 3.5C 12hS0 19S 14.￿2 467 1.8 149 Ik) 37,388 31.706 2.462 25 5.5CX) 20￿5 50 Im) 20.085 Propert WO1￿ Proi&t FEP Progromm HwlthSW￿ceDÈv￿opTy￿Tht In) 10.0(X) 422T3 15.0(X) 9.9n 30.509 29 11.764 15.1 Totd restricted funth 45.590 851.975 1.570.519 807.995 135.042 24 Anolysk%oFCharityneta5sets betwwfunds UnrestrKted Restr￿ Total Fund tokinces atJ D¢¢entsr 2020 Qre represenied W.. F￿ed oss¢ts Inves1r￿Tr[S Curreni ossets 843470 1.092.384 96&195 15125651 843470 1.092284 2,747.059 11.485.5391 1458.7961 150,0001 1.783B64 1972.9741 1458,7961 Long lermlio￿[1tLes 150,0001 2,336,484 352,094 2,888,578 UnreStr￿ted Restrict￿ Totttl Fund tolonces aty D¢centsr 2019 or¢TePTesenred ￿.. Fvxed oss¢ts InvesirÈnrs Curr¢ni ossets 1.082.945 1.088,789 623.708 1810,1981 1.082245 1.088.789 2.87&421 12,171,301) 1755.5681 150.0001 2,251,713 11261,1031 1755.5681 Long ierrnl1o￿L1tLes I￿.000) 1.935,2 135.042 2.070.286 25 Reloted Porty Apori fromrhe GIFtAid rronsferof profirs fTomNA(L M¢rchondise Lid os detoiled In Noi¢10.th¢rechorged stafFcosr5 of £11.218ond th¢ 15,000 chorgÈ lor ttdffunistroiimond mÈrthandtse12019.. £&oooI IhÈrÈorÈnootherrelttted porty transottions In Ihe yeorl2019 nonel. Ai the yeor endthÈ$U￿￿ltsry owed Ihechority £44,99612019-. £32,991). 26 Grfts in kind Crohn's & Cdilis UKrÈcÈived gifts in kind duringtheyÈttrrÈlttringttsthe wxjds ond servicÈs 100 value of £72,543. This re￿ted tDGwle grttntslus$86,369 cmvÈrtedoi$1.37/£1 @ 31.12201 £63,043ttnd olgotspDrtttÈworktti o volueOf￿.So0. Th*e ttmnis hovenoi kÈn included inthÈf1nDnt￿[gtOteM￿ftis os theirvolueis not considered to bemoterioL 36 **Crohn’s & Colitis UK** **Annual Report and Financial Statements 2020** |**27**
**Consolidated Statement of Financial Activities**
**for the year ended 31 December 2019**
**Income from:**
Donations and legacies
2
Charitable activities
5
Other trading activities
3
Investments
4
Other
**Total income**
**Expenditure on:**
Raising funds
9
Charitable activities:
Grantmaking
11
Supporter Services
Marketing and Communications
Policy, Public Affairs and Campaigns
Networks & Volunteering
Membership costs
**Total expenditure**
6
**Net income/(expenditure) before**
**investment gains/(losses)**
Gains/(losses) on investments
17
**Net income/(expenditure)**
Transfers between funds
30
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
30
**Total funds carried forward**|**Unrestricted**
**Restricted**
**Total**
**funds**
**funds**
**funds**
**2019**
**2019**
**2019**
**£**
**£**
**£**| |---|---| ||| ||2,012,575
107,369
2,119,944
27,916.00
1,103,217
1,131,133
747,197
146,089
893,286
794,626
44,650
839,276
806,685
153,967
960,652
407,076
15,227
422,303
646,134
-
646,134| ||**5,442,209**
**1,570,519**
**7,012,728**| ||(46,711)
(718,544)
(765,255)
88,789
-
88,789| ||42,078
(718,544)
(676,466)
(807,995)
807,995
-| ||**(765,917)**
**89,451**
**(676,466)**
2,701,161
45,591
2,746,752| ||**1,935,244**
**135,042**
**2,070,286**| Annual Report and Financial Statements 2020 Crohn's & Colitis UK Administrative details Board of Trustees, officers and senior management team Life President No holder Vice Presidents Rod Mitchell Elaine Steven Boord of Trustees Sue Cherrie (Chairman) Tom Reddy (Hon Treosurer ond Vice Chair) Soroh Denselow (Hon Secretary) Graham Bell Joanne Fillingham (from Feb 2020) Dr Gill Holdsworth (until end 2020) Lindsay Keir (from Feb 2020) Ashish Patel (from Feb 2020) Arnonda Quincey Alice Roth (frorn Feb 2020) Caroline Silke (until end 2020) Justine Woolf Co-opted Advisers Dr Borney Hawthorne- Chief Medical Adviser Isobel Moson- IBD Nursng Adviser Deborah Hodges- Safeguarding and HR (until end 2020) Senior Leadership Team Sarah Sleet, Chief Executive Andrew Adig Director of Finance and Corporate Services Rukshona Kopasi, Director of Health Service Development (until Aug 2020) Dan McLeon, Director of Marketing Communications and Membership Helen Terry, Director of Research (until Oct 2020) Claire WolsN Director of Income Generotion Ruth Wakeman, Director of Information und Support Services Board Committees Research Strategy and Funding Cornmittee Dr Gill Holdsworth (Chair until end 2020) Dr Lindsay Keir (Choir Elect) Sorah Denselow Prof. Ailsa Hart Dr Borney Howthorne Mr Omar Foiz (until Nov 2020) Dr Karen Kemp Prof. Christine Norton Dr Miles Parkes Prof. David Rampton (until Nov 2020) Prof. Richord Russell Koti Simpson Sorah Sleet (Ex officio) Helen Terry (Ex officio until Oct 2020) Finonce and Audit Committee Tom Reddy (Chair) Sue Cherrie Angus McLean Caroline Silke (until end 2020) Justine Woolf Andrew Adie (Ex officio) Kote Metcolfe (Ex officio) Sorah Sleet (Ex officio) IT/CRM Project Group This group stood down in January 2020 Graharn Bell (Chair) Andrew Adie Productle (external odviserl 38 Annual Report and Financial Statements 2020 Crohn's & Colitis UK Ruth Wokeman (Ex officio from Oct 2020) Saroh Sleet People and Organisational Development Committee Deborah Hodges (Chair until April 2020) Arnonda Quincey (Chair from Muy 2020) Graham Bell (from April 2020) Sue Cherrie Justine Woolf (from April 2020) Jonice Byrne (Ex officio) Sorah Sleet (Ex officio) Governance Committee This committee stood down in November 2020 Soruh Denselow (Choir) Sue Cherrie Deborah Hodges Tim Mutum Torn Mytton Jone Roberts (Ex officio) Sorah Sleet (Ex officio) Professional services Auditors Price Builey LLP 3 Floor 24 Old Bond Street Moufair LONDON W1S 4AP Solicitors Bates, Wells & Braithwaite 10 Queen Street Place London EC4R1BE Debenhams Ottowoy Solicitors Ivy House 107 St. Peter s Street St. Albans Herts AL13EW Bonkers Principal bankers: Lloyds Bonk plc 36 Chequer Street St. Albans Herts AL13YQ Other Televant bankers- CCLA Senotor House 85 Queen Victoria Street LONDON EC4V 4ET Clydesdale Bank 4th Floor, Verulam Point Stotion Woy St. Albans Herts AL15HE Close Brothers Treasury 10 Crown Ploza London EC2A4FT Santander Corporate & Commercial 2 Triton Squore. Regent's Place, London. NW13AN Metro Bank One Southampton Row LONDON, WC18 SHA 39 Annual Report and Financial Statements 2020 Crohn's & Colitis UK Thank you so much We ore incredibly grateful to each ond every one of our supporters for enabling us to reoch so many people living with Crohn s, Colitis and other forms of IBD in 2020. For more information about who we ore, what we do and how you con help, please get in touch. Crohn s & Colitis UK Helios Court 1 Bishops Square HATFIELD Herts AL10 9NE Office Direct Line.. 01727 830038 rvi (including ondP rvi 0300 222 5700 Monday to Friday.. 09=00-17..00 or email hel line crohnsundcolitis.or Follow us Fucebook=/ hn Twitter.. CrohnsColitisUK Instograrn.. YouTube'. www. outube.com/user/crohnsandcolitisuk Linkedln.. Crohns and Colitis UK 40